Keywords: besivance, oked, fda, ocular, specialist, bausch, lomb

B&L's Besivance OKed by FDA

Article | 29 May 2009

US ocular specialist Bausch & Lomb says that the Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension) 0.6% for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bausch & Lomb

Go to company listing

Related Drugs

Besifloxacin Ophthalmic Suspension

Besivance

Go to drug listing